Symptomatic treatment of nasal and ocular symptoms of seasonal and persistent allergic rhinitis, chronic idiopathic urticaria.
Composition and form of release
Dosage form – tablets. The active ingredient is cetirizine dihydrochloride.
Zodak is used in the treatment of seasonal or year-round allergic rhinitis and conjunctivitis, hay fever, urticaria, itchy allergic dermatoses and Quincke’s edema.
Zodak is not prescribed to patients with severe hepatic insufficiency, hereditary galactose intolerance, glucose-galactose malabsorption syndrome, lactase deficiency. Also absolute contraindications for the use of the drug are pregnancy, intolerance to cetirizine and lactation. In pediatric practice, Zodak drops are not prescribed to children under one year of age, in the form of tablets, the drug is contraindicated in children under 6 years.
Relative contraindications to the appointment of Zodak is old age, as possible deterioration of glomerular filtration. Dosage adjustment is required when prescribing the drug to patients with severe renal impairment.
Use during pregnancy and breastfeeding
Pregnancy and lactation are absolute contraindications for the appointment of the drug Zodak.
Method of application and dose
Zodak tablets should be taken without chewing. Children over 12 years of age and adults should take 10 mg per day.
With overdose of Zodak, patients experience increased anxiety, dizziness, dilated pupils, headaches, irritability, drowsiness, tremor, stupor, tachycardia, urinary retention and diarrhea.
In case of drug overdose, symptomatic treatment and gastric lavage are indicated. Hemodialysis is ineffective.
Zodak does not have a significant sedative effect, but in some patients there is a development of accommodation disorders of the eyes, dry mouth, difficulty urinating, headaches and dizziness.
Conditions and terms of storage
Zodak should be stored in the original packaging in places that are protected from moisture and light. Shelf life – 3 years.